---
layout: post
title: "The Capital Group Companies, Inc.增持药明生物(02269)约553.63万股 每股作价约56.08港元"
date: 2022-02-15 17:56:32 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02269" data-code="02269|116|5" data-code2="02269|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02269&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02269_0" data-code="K 02269|116|5" data-code2="K 02269|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>香港联交所最新资料显示，2月11日，The Capital Group Companies， Inc。增持药明生物(02269)553.6316万股，每股作价56.077港元，总金额约为3.1亿港元。增持后最新持股数目约为2.97亿股，最新持股比例为7.05%。<br /></p><center><img src="https://dfscdn.dfcfw.com/download/D24857853522743511216_w2158h479.jpg" alt="02269.png" title="1644918201461981.png" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202152277343719>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)